骨髓
前列腺癌
病理
腹腔注射
移植
医学
癌症
内分泌学
内科学
作者
Tong Liu,Fei Luo,E Du,Li Wang,Jianan Wang,Kuo Yang
出处
期刊:Chinese journal of experimental surgery
日期:2018-07-08
卷期号:35 (7): 1357-1360
标识
DOI:10.3760/cma.j.issn.1001-9030.2018.07.054
摘要
Objective
To establish the green fluorescent protein (GFP) bone-marrow transplanted mice model and N-methyl nitrosourea (MNU)-induced model mice model.
Methods
C57BL/6 mice were irradiated with different dose from 137Cs respectively, then transplanted with new bone-marrow cells, the mouse weight, survival rate and WBC in peripheral blood were obtained to get the optimized 137Cs BMT radiation dose, at a rate of 0.708 Gy/min. Then GFP bone-marrow transplanted mice were established using the optimum dose. The GFP bone-marrow transplanted mice model were tested by flow cytometry analysis. MNU were injected in prostate of C57BL/6 mice combining with testosterone propionate subcutaneous and intraperitoneal injection. The occurrence and progression of prostate cancer were evaluated by hematoxylin and eosin (HE) staining to test the MNU-induced prostate cancer mice model.
Results
8.5 Gy was the optimum 137Cs BMT radiation dose, at a rate of 0.708 Gy/min. GFP-positive rate of peripheral non-erythroid cells was (85.3±7.2)% 4 weeks after marrow transplantation, and GFP-positive rate of bone marrow cells was (95.2±2.5)% 28 weeks after marrow transplantation. The tumor incidence of MNU-induced mice was 78% (39/50), and the changing process of the prostate was similar with human in histology.
Conclusion
The GFP bone-marrow transplanted mice model and MNU-induced model mice model were successfully established.
Key words:
Bone marrow transplantation; Prostate cancer; Bone marrow derived cells; N-methyl nitrosourea
科研通智能强力驱动
Strongly Powered by AbleSci AI